Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters.
The gut microbiome in patients with chronic lymphocytic leukemia.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Unraveling the antiviral activity of plitidepsin by subcellular and morphological analysis.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Host Transcriptome and Microbiota Signatures Prior to Immunization Profile Vaccine Humoral Responsiveness.
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.